Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02194829 |
|---|---|
| Brief Title: | Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Previously Untreated Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery |
| First Submitted : | July 16, 2014 |
| First Submitted that Met QC Criteria : | July 16, 2014 |
| First Posted : | July 18, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | December 10, 2020 |
| Last Update Posted : | December 11, 2020 |